Loading…
Please register to continue your trial period!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Recent studies have increasingly indicated a link between gut microbiota and the onset of obesity, which opens up the potential for using probiotics as a treatment method. Specifically, Bifidobacterium breve B-3 has been shown to have an anti-obesity effect in mice that have been induced with obesity through a high-fat diet (1).
This is a randomized, double-blind, parallel-group comparative clinical trial studying Bifidobacterium breve B-3 (5 × 10^10 CFU per three capsules) or placebo (3 capsules daily for 12 weeks) in fifty-two recruited adult volunteers with a tendency for […